Diabetes, metformin and cancer risk in myotonic dystrophy type I-Reference-Cited by-同舟云学术

Diabetes, metformin and cancer risk in myotonic dystrophy type I

Published:2019-12-19 Issue:3 Volume:147 Page:785-792
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Alsaggaf Rotana¹²^ORCID,Pfeiffer Ruth M.³^ORCID,Wang Youjin¹^ORCID,St. George Diane Marie M.²,Zhan Min²,Wagner Kathryn R.⁴⁵,Amr Sania²⁶^ORCID,Greene Mark H.¹,Gadalla Shahinaz M.¹

Affiliation:

1. Clinical Genetics Branch, Division of Cancer Epidemiology and GeneticsNational Cancer Institute Bethesda MD

2. Department of Epidemiology and Public HealthUniversity of Maryland Baltimore MD

3. Biostatistics Branch, Division of Cancer Epidemiology and GeneticsNational Cancer Institute Bethesda MD

4. Hugo W. Moser Research Institute at Kennedy Krieger Institute Baltimore MD

5. Departments of Neurology and NeuroscienceJohns Hopkins University School of Medicine Baltimore MD

6. Marlene and Stuart Greenebaum Comprehensive Cancer CenterUniversity of Maryland Baltimore MD

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32801

Reference50 articles.

1. Myotonic Dystrophy

2. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member

3. Myotonic Dystrophy Mutation: an Unstable CTG Repeat in the 3′ Untranslated region of the Gene

4. Cancer Risk Among Patients With Myotonic Muscular Dystrophy

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of glucose-lowering drug target and risk of gastrointestinal cancer: a mendelian randomization study;Cell & Bioscience;2024-03-19

2. Cancer in myotonic dystrophy: A new discovery in an old disease;Muscle & Nerve;2023-05-24

3. Myotonic dystrophy type 1 in the COVID-19 era;Neurological Sciences;2023-05-08

4. Myotonic Dystrophies;Current Clinical Neurology;2023

5. Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes;Current Oncology Reports;2022-11-29